Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes

scientific article published on 9 March 2012

Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PLoSO...732400L
P356DOI10.1371/JOURNAL.PONE.0032400
P932PMC publication ID3302873
P698PubMed publication ID22427834
P5875ResearchGate publication ID221716245

P50authorWendy BarclayQ20005716
Munir IqbalQ61081409
Bryan CharlestonQ61162596
Simon GubbinsQ41050267
Charlotte F InmanQ56847568
Sharon M BrookesQ56847574
Veronica Njie-CarrQ57882897
P2093author name stringIan H Brown
Mick Bailey
Eric A Lefevre
COSI
Fanny Garcon
Helen Prentice
Michelle L Hill
Ruth A Elderfield
P2860cites workGenetically determined CD45 variant of value in leucocyte tracing in vivo in the pigQ71819231
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomesQ83918132
Systemic and mucosal immune responses to H1N1 influenza virus infection in pigsQ40766135
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesQ42790878
Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Anas platyrhynchos) infected experimentallyQ43175308
The epidemiology and evolution of influenza viruses in pigsQ43214794
Gene gun immunization in a preclinical model is enhanced by B7 targeting.Q44455406
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.Q45419096
Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolateQ49113490
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammalsQ22255464
Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypesQ24538783
Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigsQ27334919
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyQ28751886
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humansQ29619059
Cell-mediated protection in influenza infection.Q30353071
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs.Q30378835
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.Q30386068
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infectionQ30388857
Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virusQ30391898
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workersQ30395583
Long-term evolution and transmission dynamics of swine influenza A virusQ30403142
Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.Q30403679
Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distributionQ33692187
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protectionQ34807008
Protective B cell responses to flu--no fluke!Q35158499
Haemagglutination-inhibiting antibody to influenza virusQ35747515
Vaccine Adjuvants: Putting Innate Immunity to WorkQ36168232
Lymphocyte development in fetal piglets: facts and surprisesQ36250144
Type I interferon as a stimulus for cross-primingQ37027815
Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine.Q39580627
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectimmunizationQ1415366
influenza vaccineQ383260
P304page(s)e32400
P577publication date2012-03-09
P1433published inPLOS OneQ564954
P1476titleImmune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes
P478volume7

Reverse relations

cites work (P2860)
Q30421502Advances in the development of universal influenza vaccines
Q30388110Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Q38067243Animal models for neonatal diseases in humans
Q27325786Dietary Enterococcus faecium NCIMB 10415 and zinc oxide stimulate immune reactions to trivalent influenza vaccination in pigs but do not affect virological response upon challenge infection
Q30394336Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09
Q35560718Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals
Q30429455Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
Q30391724Influenza A Virus Infection in Pigs Attracts Multifunctional and Cross-Reactive T Cells to the Lung.
Q37015056Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection.
Q38492768Large animal models for vaccine development and testing.
Q40603045Magnitude and kinetics of multifunctional CD4+ and CD8β+ T cells in pigs infected with swine influenza A virus
Q30423733Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

Search more.